返回 Agenda
Session 9: SAE Case Study
Session Chair(s)
Mark Vieder, MBA, RPH
Vice President, Drug Safety and Pharmacovigilance
Biorasi, LLC, United States
Small groups will discuss fictional Serious Adverse Event reports from clinical trials and determine seriousness, expectedness, and causality.